Available now at MDLinx Gastroenterology: Ranked summaries of the most clinically-relevant GI literature refreshed every 24 hours, as well as MDLinx Gastroenterology exclusive content
Your Unread Messages in Gastroenterology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Liver stiffness associated with long-term response in HCV
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
GI Oncology Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
301 Trimodality Therapy for Stage II-III Carcinoma of the Esophagus: A Dose-Ranging Study of Concurrent Capecitabine, Docetaxel, and Thoracic Radiotherapy Journal of Thoracic Oncology, March 18, 2013 Clinical Article
302 Systematic Review of Dose-Volume Correlates for Structures Related to Late Swallowing Disturbances After Radiotherapy for Head and Neck Cancer Dysphagia, March 18, 2013 Clinical Article
303 Patterns of lymphatic drainage and lymph node involvement in esophageal cancer Abdominal Imaging , March 18, 2013 Review Article
304 The optimal lead insertion depth for esophageal ECG recordings with respect to atrial signal quality Journal of Electrocardiology, March 18, 2013 Clinical Article
305 miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma Digestive Diseases and Sciences, March 18, 2013 Review Article
306 BMP7 Expression in Esophageal Squamous Cell Carcinoma and Its Potential Role in Modulating Metastasis Digestive Diseases and Sciences, March 18, 2013 Review Article
307 Atrioesophageal Fistula After Surgical Unipolar Radiofrequency Atrial Ablation for Atrial Fibrillation Annals of Thoracic Surgery, March 18, 2013
308 A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas Full Text The Oncologist, March 15, 2013 Clinical Article
309 Clinical utility and interobserver agreement of autofluorescence imaging and magnification narrow-band imaging for the evaluation of Barretts esophagus: a prospective tandem study Gastrointestinal Endoscopy, March 15, 2013 Clinical Article
310 Prognostic Factors and Outcome for Patients with Esophageal Squamous Cell Carcinoma Underwent Surgical Resection Alone: Evaluation of the Seventh Edition of the American Joint Committee on Cancer Staging System for Esophageal Squamous Cell Carcinoma Journal of Thoracic Oncology, March 15, 2013 Clinical Article
311 Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study United European Gastroenterology Journal, March 15, 2013 Review Article
312 The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy Alimentary Pharmacology and Therapeutics, March 15, 2013 Clinical Article
313 Primary High-grade Neuroendocrine Carcinoma of the Esophagus: A Clinicopathologic and Immunohistochemical Study of 42 Resection Cases American Journal of Surgical Pathology , March 15, 2013 Review Article
314 Case report and review of esophageal lichen planus treated with fluticasone Full Text World Journal of Gastroenterology, March 15, 2013 Clinical Article
315 Pulmonary Embolism in a Patient with Eosinophilic Esophagitis: Causal or Coincidental Full Text Case Reports in Gastroenterology, March 15, 2013
316 Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as Palliative First-line Chemotherapy for Gastroesophageal Adenocarcinoma Anticancer Research, March 14, 2013 Clinical Article
317 Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma Tumor Biology, March 14, 2013 Clinical Article
318 Tumor Response after Low-dose Preoperative Radiotherapy Combined with Chemotherapy for Squamous Cell Esophageal Carcinoma Anticancer Research, March 13, 2013 Clinical Article
319 Impact of Surgeon Demographics and Technique on Outcomes After Esophageal Resections: A Nationwide Study Annals of Thoracic Surgery, March 13, 2013 Review Article
320 Treatment of Esophageal Variceal Hemorrhage with Self-Expanding Metal Stents as a Rescue Maneuver in a Swiss Multicentric Cohort Full Text Case Reports in Gastroenterology, March 13, 2013
As published in the NEJM, researchers in the COLONPREV study (Spain) have reported that fecal immunochemical testing (FIT) is as effective as colonoscopy in the detection of colorectal cancer (CRC). The study population was 50-69 years of age and comprised of 26,703 subjects who underwent a one-time colonoscopy and 26,599 subjects who underwent FIT every 2 years. The primary outcome measure was CRC deaths at 10 years. Participation in screening was greater in the FIT group than the colonoscopy group (34.2% vs. 24.6%). Detection of CRC was similar between the two groups (0.1%). Advanced and non-advanced adenomas were detected more frequently in the colonoscopy group than the FIT group (1.9% vs. 0.9% [OR=2.3] and 4.2% vs. 0.4% [OR=9.8], respectively).
Read the article summaryBased on a meta-analysis involving 30 observational studies and 202,965 patients, proton pump inhibitor therapy has been shown to significantly increase the risk of infection with Clostridium difficile (OR = 2.15).
Read the article summaryIn a single institution study involving 424 patients with DM and CRC, those patients treated with metformin had a 30% improvement in OS compared with patients not treated with metformin. Specifically, the metformin-treated patients had a mean survival of 76.9 months compared to 56.9 months.
Read the article summaryIndexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gut more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close